Home›People›Alan Williams
AW

Alan Williams

Chief operating officer at Adela

Executive
Updated Nov 8, 2026·Latest SEC filing Oct 19, 2026·Suggest an edit

About Alan Williams

Alan Williams became chief operating officer at Adela in May 2023. Adela develops routine blood tests for early cancer detection and ongoing cancer monitoring. His background covers product development and expanding clinical laboratory operations.

At SomaLogic, he was chief development officer and delivered large-scale protein analysis while overseeing test, software, and lab work. Earlier, he developed Ion Torrent’s first benchtop system for high-volume genetic sequencing. At Affymetrix, he developed its first chip-based platform for studying gene activity.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name Alan Williams in the role, so the role may have started earlier or lasted longer.

Adela, Inc. Current
Chief Operating Officer
2023 – Present · Foster City, CA
Adela's blood tests help clinicians detect recurrence and drug developers study treatment response.
SomaLogic
Chief Development Officer
Thermo Fisher Scientific (Ion Torrent)
Affymetrix

Key Colleagues at Startups

The people Alan Williams works with at each company, as listed on that company's latest Form D.

Adela, Inc. · Form D, Oct 19, 2026
LM
Lindsay Mateo
Chief Executive Officer and director
DB
David Bonita
Director
PB
Paul Brown
Director
DC
Daniel Diniz De Carvalho
Executive officer
AH
Anne-Renee Hartman
Co-Founder and Chief Medical Officer
Maneesh Jain
Maneesh Jain
Director
DS
David Scheer
Chairman of Adela's Board of Directors
AK

Sources

  1. SECAdela, Inc. Form D, filed Oct 19, 2026